Skip to search formSkip to main contentSkip to account menu

YM 268

Known as: YM-268, YM268 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Thiazolidines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
YM268 increases the glucose uptake, cell differentiation, and mRNA expression of glucose transporter in 3T3-L1 adipocytes.
The purpose of this study was to examine the effects of bis[4-[2,4-dioxo-5-thiazolidinyl)methyl]phenyl]methane (YM-268), a… 
1997
1997
Role of plasma insulin concentration in regulating glucose and lipid metabolism in lean and obese Zucker rats
OBJECTIVE: To determine the role of plasma insulin concentration in regulating glucose and lipid metabolism in insulin-resistant… 
1997
1997
Insulin sensitizer YM268 ameliorates insulin resistance by normalizing the decreased content of GLUT4 in adipose tissue of obese Zucker rats.
Genetically obese Zucker rats exhibit mild hyperglycaemia and hyperinsulinaemia suggesting the existence of peripheral insulin… 
1997
1997
Thiazolidinediones and their effects on glucose transporters.
Recently, considerable attention has been paid to a promising new family of antidiabetic therapeutic agents, the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)